Moxonidine Sandoz (Moxonidine)

• Moxonidine is used as an antihypertensive agent targeting the central imidazoline I1 receptors to control blood pressure.
• Essential hypertension: reduces systolic and diastolic blood pressure in patients with primary (essential) hypertension.

• Moxonidine selectively stimulates central imidazoline I1 receptors, which decreases sympathetic outflow from the brainstem. This reduction in sympathetic nervous system activity leads to lower peripheral vascular resistance and heart rate, resulting in a decrease in arterial blood pressure.

Moxonidine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Dry mouth: sensation of oral dryness.
• Fatigue: feeling of reduced energy.
• Dizziness: light‑headedness, especially on standing.
• Headache: mild to moderate cranial pain.
• Nausea: upset stomach with urge to vomit.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure requiring medical attention.
• Bradycardia: unusually slow heart rate.
• Allergic reactions: rash, itching, swelling, or difficulty breathing.
• Liver enzyme elevation: abnormal hepatic function tests.
• Skin rash: widespread or severe dermatologic reaction.
• Depression or mood changes: notable alterations in mental state.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential risks.

• Blood pressure monitoring: regularly check to avoid excessive hypotension.
• Renal impairment: adjust dose or use with caution in reduced kidney function.
• Cardiovascular disease: use carefully in patients with existing heart conditions.
• Discontinuation: avoid abrupt cessation; taper if clinically indicated.
• Hypersensitivity: discontinue if allergic reaction occurs.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Moxonidine can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

• Other centrally acting antihypertensives: may cause additive blood‑pressure lowering effects.
• Potent CYP2D6 inhibitors: can increase plasma concentrations of moxonidine.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance hypotensive response.

• NSAIDs: can attenuate antihypertensive effect.
• Beta‑blockers: may require dose adjustment.
• ACE inhibitors or ARBs: monitor for excessive blood‑pressure reduction.
• Alcohol: can increase dizziness and hypotension.